These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34087995)

  • 1. Generation of Alagille syndrome derived induced pluripotent stem cell line carrying heterozygous mutation in the JAGGED-1 gene at splicing site (Chr20: 10,629,709C>A) before exon 11.
    Zhu W; Cheng YS; Xu M; Farkhondeh A; Beers J; Zou J; Liu C; Baumgaertel K; Rodems S; Zheng W
    Stem Cell Res; 2021 May; 53():102366. PubMed ID: 34087995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1.
    Brooks BM; Pradhan M; Cheng YS; Gorshkov K; Farkhondeh A; Chen CZ; Beers J; Liu C; Baumgaertel K; Rodems S; Zheng W
    Stem Cell Res; 2021 Jul; 54():102447. PubMed ID: 34198154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene.
    Hatim O; Pavlinov I; Xu M; Linask K; Beers J; Liu C; Baumgärtel K; Gilbert M; Spinner N; Chen C; Zou J; Zheng W
    Stem Cell Res; 2023 Dec; 73():103231. PubMed ID: 37890331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an Alagille Syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi036-A) carrying a heterozygous mutation (p.Cys693*) in the JAG1 gene.
    Hatim O; Xu M; Pavlinov I; Linask K; Beers J; Zou J; Liu C; Rodems S; Baumgärtel K; Gilbert MA; Spinner NB; Chen C; Zheng W
    Stem Cell Res; 2024 Jun; 77():103429. PubMed ID: 38703666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of iPSC line NCHi012-A from a patient with Alagille syndrome and heterozygous pathogenic variant in the JAG1 gene.
    Cunningham D; Stanberry I; Ye S; Alonzo M; Zhao MT; Garg V; Lilly B
    Stem Cell Res; 2023 Sep; 71():103177. PubMed ID: 37549562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an induced pluripotent stem cell line NCHi011-A from a 23-year-old female with Alagille Syndrome harboring a heterozygous JAG1 pathogenic variant.
    Stanberry I; Cunningham D; Ye S; Alonzo M; Zhao MT; Garg V; Lilly B
    Stem Cell Res; 2023 Oct; 72():103213. PubMed ID: 37774637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a human induced pluripotent stem cell line (SDQLCHi037-A) from a patient with Alagille syndrome carrying heterozygous mutation in JAG1 gene.
    Wang B; Yang L; Li Y; Gao M; Zhang H; Yang X; Guan J; Liu Y; Gai Z
    Stem Cell Res; 2021 Mar; 51():102162. PubMed ID: 33465531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.
    Andersson ER; Chivukula IV; Hankeova S; Sjöqvist M; Tsoi YL; Ramsköld D; Masek J; Elmansuri A; Hoogendoorn A; Vazquez E; Storvall H; Netušilová J; Huch M; Fischler B; Ellis E; Contreras A; Nemeth A; Chien KC; Clevers H; Sandberg R; Bryja V; Lendahl U
    Gastroenterology; 2018 Mar; 154(4):1080-1095. PubMed ID: 29162437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of JAG1 gene c.1615C > T heterozygous mutation human embryonic stem cell line (SDQLCHe001-A) using cytosine base editor.
    Li Y; Wan Z; Wang B; Zhang H; Guan J; Yang X; Jin X; Ma X; Liu Y
    Stem Cell Res; 2023 Aug; 70():103120. PubMed ID: 37245339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alagille syndrome in a Vietnamese cohort: mutation analysis and assessment of facial features.
    Lin HC; Le Hoang P; Hutchinson A; Chao G; Gerfen J; Loomes KM; Krantz I; Kamath BM; Spinner NB
    Am J Med Genet A; 2012 May; 158A(5):1005-13. PubMed ID: 22488849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic Novel Heterozygous Variant c.1076c>T p. (Ser359Phe) chr1: 120512166 in NOTCH2 Gene, Type 2 Alagille Syndrome Causing Neonatal Cholestasis: A Case Report.
    Uddin MS; Al Fulayyih S; Al Denaini FF; Al Hatlani MM
    Am J Case Rep; 2022 Oct; 23():e935840. PubMed ID: 36201396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature senescence of the liver in Alagille patients.
    Jannone G; de Magnée C; Tambucci R; Evraerts J; Ravau J; Najimi M; Sokal EM
    PLoS One; 2023; 18(4):e0285019. PubMed ID: 37099537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification.
    Gilbert MA; Bauer RC; Rajagopalan R; Grochowski CM; Chao G; McEldrew D; Nassur JA; Rand EB; Krock BL; Kamath BM; Krantz ID; Piccoli DA; Loomes KM; Spinner NB
    Hum Mutat; 2019 Dec; 40(12):2197-2220. PubMed ID: 31343788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alagille syndrome caused by NOTCH2 mutation presented atypical pathological changes.
    ShenTu Y; Mi X; Tang D; Jiang Y; Gao L; Ma X; Zhou B; Yang W; Shi J; Lan D; Chen G; Gong L
    Clin Chim Acta; 2021 Oct; 521():258-263. PubMed ID: 34332988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.
    Adams JM; Huppert KA; Castro EC; Lopez MF; Niknejad N; Subramanian S; Zarrin-Khameh N; Finegold MJ; Huppert SS; Jafar-Nejad H
    Hepatology; 2020 Apr; 71(4):1331-1349. PubMed ID: 31469182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alagille syndrome and risk for hepatocellular carcinoma: Need for increased surveillance in adults with mild liver phenotypes.
    Schindler EA; Gilbert MA; Piccoli DA; Spinner NB; Krantz ID; Loomes KM
    Am J Med Genet A; 2021 Mar; 185(3):719-731. PubMed ID: 33369123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
    McCright B; Lozier J; Gridley T
    Development; 2002 Feb; 129(4):1075-82. PubMed ID: 11861489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment.
    Kohut TJ; Gilbert MA; Loomes KM
    Semin Liver Dis; 2021 Nov; 41(4):525-537. PubMed ID: 34215014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOTCH2 mutations in Alagille syndrome.
    Kamath BM; Bauer RC; Loomes KM; Chao G; Gerfen J; Hutchinson A; Hardikar W; Hirschfield G; Jara P; Krantz ID; Lapunzina P; Leonard L; Ling S; Ng VL; Hoang PL; Piccoli DA; Spinner NB
    J Med Genet; 2012 Feb; 49(2):138-44. PubMed ID: 22209762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of JAG1 gene mutations in Polish patients with Alagille syndrome.
    Jurkiewicz D; Gliwicz D; Ciara E; Gerfen J; Pelc M; Piekutowska-Abramczuk D; Kugaudo M; Chrzanowska K; Spinner NB; Krajewska-Walasek M
    J Appl Genet; 2014 Aug; 55(3):329-36. PubMed ID: 24748328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.